Amitiza a big success????

I hear it's our number two drug!?!

Bad news....It's not your drug you are just contract reps for Sucampo. You better hope that continues if you are a contract employee otherwise know as GSO division.

What about Provigil? it will do over 1 billion this year

Bad news again.....not your drug you are contract reps.

Originally Posted by Anonymous

I hear it's our number two drug!?!

Hey, the only reason it is doing so well is that Zelnorm was taken off the market. It's still dollars and cents but don't pat yourselves too hard.
Sucampo was given a BIG gift!

Originally Posted by Anonymous

Hey, the only reason it is doing so well is that Zelnorm was taken off the market. It's still dollars and cents but don't pat yourselves too hard.
Sucampo was given a BIG gift!

Well, you're probably just a pain in the ass Rozerem Rep.

Hey. Makes sense that Amitiza is the number two drug. After all, it is for number "2" as it is.

Originally Posted by Anonymous

Well, you're probably just a pain in the ass Rozerem Rep.

And your just a fucking moron! it's little shits like you that make people actually working hard want to beat someone!

Originally Posted by Anonymous

Hey, the only reason it is doing so well is that Zelnorm was taken off the market. It's still dollars and cents but don't pat yourselves too hard.
Sucampo was given a BIG gift!

Amitiza is finished when Zelnorm is back on the market. Physicians do not want to be prescribing a prostaglandin!

Originally Posted by Anonymous

Amitiza is finished when Zelnorm is back on the market. Physicians do not want to be prescribing a prostaglandin!

No, actually GSK monkey boy that would be incorrect. What physicians want is to not KILL their patients by causing the 5ht4 receptors in the heart to release serotonin resulting in the muscle to unexpectedly contract. That's what your product does. The FDA has always been one to respond to a fat under the table check, so zelnorm probably will get on the market. I'll have fun encouraging physicians to put themselves at legal risk for causing a patients heartattack. Amitiza..It's a locally acting cash cow!

Originally Posted by Anonymous

No, actually GSK monkey boy that would be incorrect. What physicians want is to not KILL their patients by causing the 5ht4 receptors in the heart to release serotonin resulting in the muscle to unexpectedly contract. That's what your product does. The FDA has always been one to respond to a fat under the table check, so zelnorm probably will get on the market. I'll have fun encouraging physicians to put themselves at legal risk for causing a patients heartattack. Amitiza..It's a locally acting cash cow!

You don't even know what company make Zelnorm!! GSK what a joke.
Don't worry, if Zelnorm does even come back NOVARTIS will have enough safety studies. Otherwise FDA would never let it back. I don't work for Novartis or Takeda but take it from me there are plenty of Drs that would jump back to Zelnorm if it came back. Just enjoy the cash cow while its here cause it might not be here forever

Originally Posted by Anonymous

You don't even know what company make Zelnorm!! GSK what a joke.
Don't worry, if Zelnorm does even come back NOVARTIS will have enough safety studies. Otherwise FDA would never let it back. I don't work for Novartis or Takeda but take it from me there are plenty of Drs that would jump back to Zelnorm if it came back. Just enjoy the cash cow while its here cause it might not be here forever

Amitiza is being positioned in the elderly population so even if Zelnorm comes back, it won't be in the geriatric population that can't be touched.

Originally Posted by Anonymous

Hey. Makes sense that Amitiza is the number two drug. After all, it is for number "2" as it is.

Just trolling through - this post is funny!

Originally Posted by Anonymous

Amitiza is finished when Zelnorm is back on the market. Physicians do not want to be prescribing a prostaglandin!

Why???

Originally Posted by Anonymous

Why???

Prostaglandins kill!! DUMBASS

Originally Posted by Anonymous

Amitiza is finished when Zelnorm is back on the market. Physicians do not want to be prescribing a prostaglandin!

EAST HANOVER, N.J., July 27 /PRNewswire/ -- In cooperation with the US Food and Drug Administration (FDA), Novartis has established a restricted access program for Zelnorm(R) (tegaserod maleate) so that patients in need of this medicine can be considered for treatment.

The program, called a treatment IND, is designed to help women in the US under 55 years of age who suffer from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), and for whom no other treatment has provided satisfactory relief and/or patients who had satisfactory improvement of their symptoms with prior Zelnorm treatment for IBS-C or CIC. Novartis and the FDA are moving forward with this program because of requests from physicians and patients following the marketing suspension of Zelnorm in March 2007.

Treatment INDs are generally used to allow restricted access to medications for patients in need if no comparable alternative drug or therapy is available to treat the disease. Patients given access through a treatment IND must meet specific FDA-approved criteria for enrollment.

Through the program, appropriate female patients with IBS-C or CIC who are assessed by their physicians as being in critical need can have access to Zelnorm for relief of the often painful and disruptive symptoms associated with these conditions. The program protocol and consent materials are designed to ensure that patients and physicians are fully informed of the potential risks and benefits of Zelnorm.

To be considered for access to Zelnorm through the treatment IND, patients must have IBS-C or CIC and meet the specific criteria in the treatment IND protocol. To become part of the treatment IND, patients should contact their physicians to inquire about the protocol and evaluate if they meet the criteria. For further details of the program's protocol, physicians can call 866-248-1348 or 888-669-6682 or go to www.zelnorm.com.

For patients who do not meet the criteria of the treatment IND but have an urgent need for Zelnorm based on a life-threatening or severely debilitating condition, there may be an alternative option available through the FDA. Physicians may inquire about this potential access option by contacting Novartis at (888-NOW-NOVA) or the FDA CDER Division of Drug Information at 301-827-4570 or www.fda.gov/cder.

Novartis suspended US marketing and sales of Zelnorm as a result of an FDA request in order to permit further discussion of its benefit/risk profile. This decision was based on a review of a new retrospective analysis of pooled clinical trial data which showed that the incidence of cardiovascular ischemic events was higher in patients taking Zelnorm than in those taking placebo. However, no causal relationship between Zelnorm and cardiovascular ischemic events has been demonstrated.

Novartis has extensively studied Zelnorm and believes that this medicine provides important benefits for appropriate patients. Novartis is in discussions with the FDA to better understand the findings and to determine appropriate next steps.



Not saying that Zelnorm is back on the market but this could be the beginning of its course. Notice how it says Drs and patients have both requested it. If Zelnorm ever does come back Drs will jump back in without a doubt.

Originally Posted by Anonymous

Prostaglandins kill!! DUMBASS

Then why is it on the market?

Think before you answer, prick!

Originally Posted by Anonymous

Prostaglandins kill!! DUMBASS

let me guess....you're a dumdass, stupid blonde who 'don't know nuthin'...prostaglndins kill LOL...do a little homework before you open your skanky dumb mouth.

Originally Posted by Anonymous

Amitiza is finished when Zelnorm is back on the market. Physicians do not want to be prescribing a prostaglandin!

1. It's not a prostoglandin, it's a prostone.

2. They don't kill, they cause spontaneous abortions, which Amitiza never has.

3. If you are going to "troll" a board, know better facts.

Originally Posted by Anonymous

1. It's not a prostoglandin, it's a prostone.

2. They don't kill, they cause spontaneous abortions, which Amitiza never has.

3. If you are going to "troll" a board, know better facts.

Yeah and Zelnorm had never had any cardiac issues until someone did a meta analysis of restrospective studies. Anyway you look at it any drug can cause problems and Amitiza may have issues you just don't know about but that can come out in the future. Give it a few more years and something will come up!